Answers are grounded in this paper and cite their sources.
Case series reports functional outcomes of type 4 pelvic resection in malignant tumours, indicating reasonable short-term results despite complications.
BackgroundType 4 pelvic resections for malignant pelvic tumours are complex procedures requiring meticulous surgical planning to balance oncological control and preservation of hip joint function. Reconstruction with a high hip centre is one strategy to restore a mobile hip joint after ilium resection.MethodsThis retrospective case series reviews eight patients (5 males, 3 females; mean age 52.5 years, range 36-70) who underwent Type 4 pelvic resection and high hip centre reconstruction at a single institution. Tumour histologies included chondrosarcoma (n = 5), Ewing's sarcoma (n = 1), malignant hemangiopericytoma (n = 1), and metastatic papillary thyroid carcinoma (n = 1). The mean follow-up duration was 44 months (24-69 months).ResultsThe average surgical time was 4 h (range 3.5-6 h) with a mean estimated blood loss of 1500 ml (range 1200-2000 ml). Complications occurred in 50% of cases, including deep wound infection (n = 1), seroma formation (n = 2), and implant failure (n = 1). There were no local recurrences. Oncological outcomes showed that 3 patients died due to disease progression, 1 remains alive with disease, and 4 are disease-free. Functional outcomes were assessed using the MSTS and TESS scoring systems, with mean scores of 63.4% (range 33.3%-80.3%) and 65.7% (range 25%-86.6%), respectively.ConclusionType 4 pelvic resection with high hip centre reconstruction is a viable option for managing select malignant pelvic tumours, offering reasonable short-term oncological control and functional outcomes despite a notable complication rate. Careful patient selection and surgical planning remain essential.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: